Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for constructing retinal pigment degeneration disease model by utilizing Gm20541 gene and application

A technology for retinal pigmentation and degenerative diseases, applied to other methods of inserting foreign genetic materials, stably introducing foreign DNA into chromosomes, recombinant DNA technology, etc., can solve the lack of RP disease models, unclear pathogenic mechanisms of RP, RP Difficulties in clinical diagnosis and treatment of diseases, etc., to achieve the effect of broad application prospects

Active Publication Date: 2020-06-12
SICHUAN PROVINCIAL PEOPLES HOSPITAL
View PDF2 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In addition, due to the high heterogeneity of RP in clinical phenotype and genetic pattern, many RP pathogenic mechanisms are still unclear, which brings great difficulties to the clinical diagnosis and treatment of RP diseases. Research on the pathogenic mechanism is imminent
[0004] At present, there is a lack of corresponding RP disease models

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for constructing retinal pigment degeneration disease model by utilizing Gm20541 gene and application
  • Method for constructing retinal pigment degeneration disease model by utilizing Gm20541 gene and application
  • Method for constructing retinal pigment degeneration disease model by utilizing Gm20541 gene and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] 1 RT-PCR method was used to detect the expression of Gm20541 gene in different tissues and organs.

[0053] Methods: Total RNA was extracted from mouse brain, liver, retina, intestine, muscle, heart, kidney and spleen, and cDNA was synthesized with a cDNA synthesis kit (Invitrogen, Waltham, MA, USA). Primers were designed according to the cDNA sequence of Gm20541:

[0054] Gm20541-cDNA-F: 5'-TCGGTCTCATCTTCATTCCC-3';

[0055] Gm20541-cDNA-R: 5'-GGAAGGCTCTGTTCCGGTAT-3'.

[0056] Using the extracted cDNA as a template, RT-PCR was performed. After amplification, electrophoresis was carried out, and the results were shown in figure 1 .

[0057] see results figure 1 In A and B, it can be seen that the expression of Gm20541 gene in mouse brain, liver, retina, intestine, muscle, heart, kidney and spleen was detected by RT-PCR method, and it was found that in these tissues and organs, Gm20541 was expressed expression, indicating that the gene may play an important role in ...

Embodiment 2

[0071] In this example, mouse is used as the target animal, and the method for constructing the retinitis pigmentosa disease model provided by the present invention is described. The route of Gm20541 gene knockout is as follows: figure 2 As shown, the specific operation is as follows:

[0072] Steps for obtaining knockout mice:

[0073] 1 The 5' arm homologous to the mouse Gm20541 gene, the expression cassette containing the reporter gene GFP, the expression cassette with the NEO resistance gene, the third exon and the 3' end of the loxP site arranged in the same direction at both ends Arm cloned into BAC vector ( figure 2 ) to replace the third exon of the Gm20541 gene to be knocked out;

[0074] 2 Using DNA homologous recombination technology to replace the third exon in the Gm20541 gene to obtain mouse embryonic stem cells with conditional knockout of the Gm20541 gene;

[0075] 3 Using the embryonic stem cells obtained in step 2 to prepare chimeric mice containing Gm20...

Embodiment 3

[0121] ERG visual acuity detection of 4-month-old Gm20541 gene knockout homozygous mice:

[0122] 1 Dark-adapted animals should be dark-adapted all night, and the environment should have absolutely no light;

[0123] Anesthesia on the 2nd day: weighing, intraperitoneal injection; deep anesthesia is appropriate;

[0124] 3 Animal fixation and mydriasis: After anesthesia is completed, the mice are fixed with adhesive tape in front of the animal test platform under dark red light illumination: it is necessary to ensure that the mice are "lying", that is, relative to the stimulation port of the flash stimulator, both eyes Highly consistent, fully exposed, drop mydriatic agent.

[0125] 4 Electrode installation: After preheating the electroretinograph (Espion Visual Electrophysiology System, Diagnosys LLC, Littleton, MA, USA), apply conductive paste to the electrode of the ear clip, clip the tail, and insert it into the "ground" interface of the amplifier; the double-ended needle ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Thicknessaaaaaaaaaa
Login to View More

Abstract

The invention discloses a method for constructing a retinal pigment degeneration disease model by utilizing a Gm20541 gene and application, and relates to the technical field of medical engineering. According to the method disclosed by the invention, a Gm20541 gene sequence in a genome in retinal precursor cells is knocked out in a specific targeting manner; a target animal shows typical retinal pigment degeneration disease characteristics; a reliable animal model is provided for research of the Gm20541 gene related retinal pigment degeneration disease, the pathogenesis and mechanism of the retinal pigment degeneration disease can be helped to be illuminated, a new target is provided for treatment or prevention of the disease, and the application prospect is wide.

Description

technical field [0001] The invention relates to the technical field of medical engineering, in particular to a method and application for constructing a retinitis pigmentosa disease model by using the Gm20541 gene. Background technique [0002] Retinitis pigmentosa (RP) is a group of hereditary blinding fundus diseases caused by abnormal retinal photoreceptors. 1 / 3500, due to the large population in my country, RP patients can reach 300,000 people, which brings a heavy burden to the family and society. At present, the diagnosis and treatment of RP face many difficulties, and there is no effective treatment, which is mainly due to its high degree of heterogeneity in clinical phenotype and genetics, and insufficient systematic research on its pathological mechanism. Typical RP patients first develop night blindness and narrow visual field due to the defect of rod cell function, and gradually develop tubular visual field until blindness; retinal pigmentation can be seen in fund...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/90A01K67/027
CPCA01K67/0275A01K2217/075A01K2227/105A01K2267/0306C12N15/90
Inventor 朱献军杨业明曲超蒋志林孙宽祥
Owner SICHUAN PROVINCIAL PEOPLES HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com